Medicine and Dentistry
Patient
100%
Survival
66%
Cancer Immunotherapy
66%
Assessment
66%
Combination Therapy
66%
Immune Checkpoint Blockade
44%
Tumor Infiltrating Lymphocyte
33%
Chemotherapeutic Agent
33%
Malignant Neoplasm
33%
Overall Survival
33%
Proteus Syndrome
33%
Mechanism of Action
33%
Drug Resistance
33%
Oncology
33%
Life
33%
Immunoglobulin
33%
Development
33%
Cancer Therapy
33%
Side Effect
33%
Drug
33%
Immunotherapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Immunotherapy
75%
Neoplasm
66%
Survival
50%
Immunoglobulin
25%
Multiple Cancer
25%
Side Effect
25%
Drug Resistance
25%
Drug Development
25%
Overall Survival
25%